CVS vs UNH
CVS and UNH side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CVSCVS HEALTH CORPORATION | UNHUnitedHealth Group Incorporated |
|---|---|---|
| Market cap | $115.40B | $365.25B |
| P/E (TTM) | 23.8 | 26.2 |
| P/B | 1.45 | 11.06 |
| P/S | 0.3x | 0.8x |
| Dividend yield | 2.94% | 2.17% |
| Revenue | $415.09B(TTM) | $450.13B(TTM) |
| Revenue growth (YoY) | 7.8% | 11.8% |
| Net income | $4.89B(TTM) | $14.12B(TTM) |
| Earnings growth (YoY) | -61.7% | -16.3% |
| EPS, diluted | $3.79(TTM) | $15.56(TTM) |
| EBIT margin | 1.2% | 4.2% |
| ROE | 2.2% | 36.5% |
| ROIC | 2.9% | 21.3% |
| Piotroski F | 6/9 | — |
| 1y total return | +21.1% | +20.6% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: CVS frente a UNH
| Métrica | CVS | UNH |
|---|---|---|
| Valor final | $13.2K | $34.4K |
| Retorno total | +31.7% | +243.7% |
| CAGR | +2.7% | +12.7% |
| Volatilidad | 28.8% | 30.0% |
| Sharpe | 0.09 | 0.41 |
| Sortino | 0.13 | 0.57 |
| Caída máxima | -56.8% | -61.4% |
Basado en 2600 días de negociación comunes, 2016-06-29 → 2026-10-30 · tasa libre de riesgo 4.16% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)